tiprankstipranks
Top Stocks
Top Analyst StocksTop Smart Score StocksTop Insiders Stocks
Popular
Stock ScreenerTop Online Growth StocksTrending StocksPenny Stock Screener
Dividend Investing
Dividend CalculatorDividend Yield CalculatorDividend StocksDividend NewsDividend Calendar
ETFs
ETF CenterSPY ETFQQQ ETF
Stock Comparison
ChatGPT StocksValue StocksAirline StocksAI StocksOil StocksBank StocksFAANG StocksCompare More Stocks…
Calendars
IPO CalendarEarnings Calendar
Popular
Dividend CalendarEconomic Calendar
New
Market HolidaysDaily Analyst RatingsDaily Insider Trading
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Stock Market NewsStock Analysis & Ideas
Popular
ETF NewsGlobal Markets NewsExpert SpotlightTipRanks LabsEarnings Reports InsightsMarket BreakdownsDividend Stock NewsCrypto News
My PortfolioMy PerformanceMy Portfolio AnalysisCrowd InsightsMy Watchlist
About Us
About TipRanksContact Us
Working with TipRanks
Enterprise SolutionsBest Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert Center
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Smart Score Stocks
Analysts' Hot Stocks
Insiders' Hot Stocks
Popular
Trending Stocks
Fastest Growing Websites
Hot
Penny Stocks
Market Movers
My Experts
Top Firms
Top Wall Street Analysts
Top Financial Bloggers
Top Corporate Insiders
Popular
Top Hedge Fund Managers
Top Individual Investors
Stock Screener
Stock Comparison
Dividend Calculator
Popular
ETF Center
Dividend Yield Calculator
Daily Stock Ratings
Daily Insider Transactions
Stock ComparisonPOPULAR COMPARISONS
Dividend Stocks
ChatGPT Stocks
Airline Stocks
AI Stocks
My Portfolio
My Performance
My Portfolio Analysis
Crowd Insights
Earnings Calendar
Popular
Dividend Calendar
Economic Calendar
New
IPO Calendar
Stock Market Holidays
Market News
ETF News
Stock Analysis & Ideas
Popular
Global Markets News
Expert Spotlight
Tipranks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
About TipRanks
For Business
Become an Affiliate
Reviews
Contact Us
Plans & Pricing

WVE Stock Latest News

Wave Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
Press ReleasesWave Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
3d ago
WVE
Wave Life Sciences expects cash to fund operations into 2025
The FlyWave Life Sciences expects cash to fund operations into 2025
3d ago
WVE
Wave Life Sciences reports Q4 EPS (47c), consensus (41c)
The FlyWave Life Sciences reports Q4 EPS (47c), consensus (41c)
3d ago
WVE
Wave Life considers direct SVB exposure ‘immaterial’
The FlyWave Life considers direct SVB exposure ‘immaterial’
14d ago
WVE
SIVB
Wave Life Sciences to Webcast Conference Call of Fourth Quarter and Full Year 2022 Financial Results on March 22, 2023
Press ReleasesWave Life Sciences to Webcast Conference Call of Fourth Quarter and Full Year 2022 Financial Results on March 22, 2023
23d ago
WVE
Wave Life Sciences to Present at the 2023 Virtual SVB Securities Global Biopharma Conference
Press ReleasesWave Life Sciences to Present at the 2023 Virtual SVB Securities Global Biopharma Conference
1M ago
WVE
ProQR Therapeutics price target raised to $5 from $2 at Raymond James
The FlyProQR Therapeutics price target raised to $5 from $2 at Raymond James
3M ago
GSK
LLY
Wave Life Sciences announces update from PoC study of WVE-N531
The FlyWave Life Sciences announces update from PoC study of WVE-N531
3M ago
WVE
Wave Life Sciences Provides Positive Update on Proof-of-Concept Study for WVE-N531 in Duchenne Muscular Dystrophy
Press ReleasesWave Life Sciences Provides Positive Update on Proof-of-Concept Study for WVE-N531 in Duchenne Muscular Dystrophy
3M ago
WVE
Biotech Alert: Searches spiking for these stocks today
The FlyBiotech Alert: Searches spiking for these stocks today
3M ago
GSK
RNA
Biotech Alert: Searches spiking for these stocks today
The FlyBiotech Alert: Searches spiking for these stocks today
3M ago
GSK
LLY
Wave Life Sciences Soars on GSK Deal
Market NewsWave Life Sciences Soars on GSK Deal
3M ago
GSK
WVE
Wave Life Sciences, GSK collaborate for oligonucleotide therapeutic development
The FlyWave Life Sciences, GSK collaborate for oligonucleotide therapeutic development
3M ago
GSK
WVE
Wave Life Sciences Reports Third Quarter 2022 Financial Results and Provides Business Update
Press ReleasesWave Life Sciences Reports Third Quarter 2022 Financial Results and Provides Business Update
4M ago
WVE
Wave Life Sciences to Present at the Stifel 2022 Healthcare Conference
Press ReleasesWave Life Sciences to Present at the Stifel 2022 Healthcare Conference
5M ago
WVE
Wave Life Sciences to Highlight Advancements from PRISM Platform at Upcoming Scientific Congresses
Press ReleasesWave Life Sciences to Highlight Advancements from PRISM Platform at Upcoming Scientific Congresses
6M ago
WVE
Wave Life Sciences Highlights Therapeutic Potential for WVE-006 for Alpha-1 Antitrypsin Deficiency and Progress Bringing RNA Editing to the Clinic During Analyst and Investor Event
Press ReleasesWave Life Sciences Highlights Therapeutic Potential for WVE-006 for Alpha-1 Antitrypsin Deficiency and Progress Bringing RNA Editing to the Clinic During Analyst and Investor Event
6M ago
WVE
Wave Life Sciences to Present at Chardan’s 6th Annual Genetic Medicines Conference
Press ReleasesWave Life Sciences to Present at Chardan’s 6th Annual Genetic Medicines Conference
6M ago
WVE
Wave Life Sciences Announces Positive Update from Phase 1b/2a SELECT-HD Trial with Initial Results Indicating Allele-Selective Target Engagement with WVE-003 in Huntington’s Disease
Press ReleasesWave Life Sciences Announces Positive Update from Phase 1b/2a SELECT-HD Trial with Initial Results Indicating Allele-Selective Target Engagement with WVE-003 in Huntington’s Disease
6M ago
WVE
Wave Life Sciences to Host Analyst and Investor Virtual Event, “Towards the Clinic: Spotlight on RNA Editing for AATD,” on September 28, 2022
Press ReleasesWave Life Sciences to Host Analyst and Investor Virtual Event, “Towards the Clinic: Spotlight on RNA Editing for AATD,” on September 28, 2022
6M ago
WVE
Why Is Wave Life Sciences Stock Surging Despite Q2 Miss?
Market NewsWhy Is Wave Life Sciences Stock Surging Despite Q2 Miss?
8M ago
WVE
Wave Life Sciences Reports Second Quarter 2022 Financial Results and Provides Business Update
Press ReleasesWave Life Sciences Reports Second Quarter 2022 Financial Results and Provides Business Update
8M ago
WVE
Key Insider Bought Shares of Wave Life Sciences; What Now?
Market NewsKey Insider Bought Shares of Wave Life Sciences; What Now?
9M ago
WVE
Billionaire Jim Simons Snaps Up These 2 Biotech Stocks
Stock Analysis & IdeasBillionaire Jim Simons Snaps Up These 2 Biotech Stocks
2y ago
WVE
ZGNX
tipranks
TipRanks is a comprehensive research tool that helps investors make better, data-driven investment decisions.
Find Us on
twitterstocktwitsfacebooklinkedininstagram
Newsletter SubscriptionEnter your email to receive our newsletter
iosandroid
SitemapTerms of UsePrivacy PolicyFAQ
Research ToolsTop Smart Score StocksTrending StocksDaily Stock RatingsStock ScreenerStock ComparisonAnalysts' Top StocksDaily Insider TransactionsInsiders' Hot StocksExpert Center
CalendarsEarnings CalendarDividend CalendarIPO CalendarStock Market Holidays
EducationGlossaryTipRanks Labs
PlansPlans & PricingAPI for Institutions
CompanyAbout TipRanksContact UsReviews
Disclaimer: The TipRanks Smart Score performance is based on backtested results. Backtested performance is not an indicator of future actual results. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. Backtested results are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. General assumptions include: XYZ firm would have been able to purchase the securities recommended by the model and the markets were sufficiently liquid to permit all trading. Changes in these assumptions may have a material impact on the backtested returns presented. Certain assumptions have been made for modeling purposes and are unlikely to be realized. No representations and warranties are made as to the reasonableness of the assumptions. This information is provided for illustrative purposes only. Backtested performance is developed with the benefit of hindsight and has inherent limitations. Specifically, backtested results do not reflect actual trading or the effect of material economic and market factors on the decision-making process. Since trades have not actually been executed, results may have under- or over-compensated for the impact, if any, of certain market factors, such as lack of liquidity, and may not reflect the impact that certain economic or market factors may have had on the decision-making process. Further, backtesting allows the security selection methodology to be adjusted until past returns are maximized. Actual performance may differ significantly from backtested performance. Backtested results are adjusted to reflect the reinvestment of dividends and other income and, except where otherwise indicated, are presented gross-of fees and do not include the effect of backtested transaction costs, management fees, performance fees or expenses, if applicable. Please note all regulatory considerations regarding the presentation of fees must be taken into account. No cash balance or cash flow is included in the calculation.